Weak sterling boosts GlaxSmithKline as new CEO takes over

LONDON (Reuters) - GlaxoSmithKline's new chief executive reported slightly better than expected first-quarter results on Wednesday, keeping the drugmaker on track to hit financial targets in 2017 as it braces for generic competition to blockbuster lung drug Advair.

from Reuters: Top News http://uk.reuters.com/article/uk-gsk-results-idUKKBN17S1F2?feedType=RSS&feedName=topNews